Press Releases

Press Releases

Antibe Therapeutics Inc. will be front-and-centre at the 4th International Conference on the Biology of Hydrogen Sulfide, to be held in Naples, Italy from June 3rd to 5th. The company’s founder and Chief Scientific Officer, John Wallace, and Antibe Scientific Advisor and Nobel Prize winner Louis Ignarro, will be making…

Press Releases

Technavio has announced the top seven leading vendors in their recent global anesthesia resuscitators market report. This research report also lists 54 other prominent vendors that are expected to impact the market during the forecast period. Competitive vendor landscape The global anesthesia resuscitators market is highly competitive and fragmented with…

Press Releases

Pharmapack Europe (#pharmapackeu), organised by UBM EMEA,is a two-day exhibition and conference dedicated to pharmaceutical packaging, drug delivery and affiliated industries. Next year’s event is on 1–2 February 2017at Paris Expo Porte de Versailles (Hall 4),Paris. 2017 marks the event’s 20th successful year, and over its lifetime it has grown…

Press Releases

The U.S. Food and Drug Administration (FDA) approved ZINBRYTA™ (daclizumab), a new once-monthly, self-administered, subcutaneous treatment for relapsing forms of multiple sclerosis (RMS), Biogen (NASDAQ: BIIB) and AbbVie (NYSE: ABBV) announced today. Because of its safety profile, the use of ZINBRYTA should generally be reserved for patients who have had…

Press Releases

Highland Therapeutics, Inc. announced today that its wholly owned subsidiary Ironshore Pharmaceuticals and Development, Inc. (“Ironshore”) has entered into an agreement with Quotient Clinical (“Quotient”) to conduct scintigraphy imaging of a new drug candidate, HLD-400, for Inflammatory Bowel Disease (IBD) using Quotient’s RapidFACT® (Rapid Formulation development And Clinical Testing) program.…

Press Releases

GnuPharma® company, an early stage pharmaceutical company, focusing on the use of natural ingredients as opposed to synthesized or non-organic molecules, began developing its theory when company co-Founder and President Chip Paul became involved with the medical cannabis campaign in Oklahoma. “I was shocked and astounded at what I could…

Press Releases

Ensemble Therapeutics, a biotechnology company focused on discovering and developing breakthrough small molecule therapies for cancer and other serious diseases, today announced that Novartis has acquired rights to expand its access to Ensemble’s interleukin-17 (IL-17) antagonist program, which was previously advanced as a joint collaboration between the two companies. This…

Press Releases

Innovus Pharmaceuticals, Inc., an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men and women's health and respiratory diseases today announced today that it has entered into an exclusive license and distribution agreement with BroadMedSAL, a Lebanese company ("BroadMed")…

Press Releases

Gilead Sciences, Inc. today announced two appointments to the company’s senior leadership team. Kevin Young CBE has been appointed Chief Operating Officer, and Martin Silverstein, MD has been appointed Executive Vice President, Strategy. Both Mr. Young and Dr. Silverstein will report to John F. Milligan, PhD, President and Chief Executive…

Press Releases

Merck, known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.46 per share of the company’s common stock for the third quarter of 2016. Payment will be made on July 8, 2016 to shareholders of record at…